Live Breaking News & Updates on Glaucoma Association Consensus

Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease
News provided by
Share this article
Share this article
SHANGHAI and HONG KONG, July 4, 2021 /PRNewswire/ Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof. Christopher Leung, Head and Clinical Professor at the Department of Ophthalmology of the University of Hong Kong (HKU) for the discovery and development of novel neuroprotective therapies for glaucoma.
Glaucoma, an optic neuropathy characterized by progressive loss of retinal ganglion cells (RGCs), is the leading cause of irreversible blindness worldwide. ....

United States , Hong Kong , University Of Hong Kong , Hong Kong General , Dianna Qian , Christopher Leung , World Glaucoma Congress Young Clinician Scientist Award , Services Alliance Global Information , American Academy Of Ophthalmology Secretariat Award , Optic Nerve Diagnostics Lab , Asia Pacific Glaucoma Society Young Investigator Award , American Academy Of Ophthalmology Senior Achievement Award , Regeneration Lab , World Information Technology , University Of Hong Kong Professor Christopher Leung , Communications Technology , World Glaucoma Congress Science Award , Communications Excellence Award , Virtual Reality Lab , Department Of Ophthalmology , World Glaucoma Association Consensus Meeting , Association For Research , Lancet Glob Health , Scientist Research Award , Clinical Professor , Glaucoma Association Consensus ,